BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288,334 | -48.3% | 7,640 | -37.5% | 0.02% | -45.7% |
| Q2 2023 | $557,290 | +12.7% | 12,232 | +0.3% | 0.04% | +2.9% |
| Q1 2023 | $494,426 | -20.7% | 12,190 | -0.4% | 0.03% | -19.0% |
| Q4 2022 | $623,874 | -5.0% | 12,240 | +0.3% | 0.04% | -16.0% |
| Q3 2022 | $657,000 | -16.1% | 12,205 | +0.1% | 0.05% | -10.7% |
| Q2 2022 | $783,000 | -17.1% | 12,190 | 0.0% | 0.06% | -13.8% |
| Q1 2022 | $945,000 | -9.7% | 12,190 | 0.0% | 0.06% | -1.5% |
| Q4 2021 | $1,047,000 | +6.8% | 12,190 | 0.0% | 0.07% | -5.7% |
| Q3 2021 | $980,000 | -0.1% | 12,190 | 0.0% | 0.07% | -1.4% |
| Q2 2021 | $981,000 | -4.6% | 12,190 | 0.0% | 0.07% | -6.6% |
| Q1 2021 | $1,028,000 | +1.7% | 12,190 | -3.3% | 0.08% | -6.2% |
| Q4 2020 | $1,011,000 | -19.4% | 12,605 | -19.2% | 0.08% | -25.7% |
| Q3 2020 | $1,255,000 | -6.6% | 15,605 | 0.0% | 0.11% | -13.5% |
| Q2 2020 | $1,344,000 | +6.1% | 15,605 | 0.0% | 0.13% | -11.3% |
| Q1 2020 | $1,267,000 | -1.9% | 15,605 | +1.1% | 0.14% | +39.2% |
| Q4 2019 | $1,291,000 | -4.4% | 15,440 | 0.0% | 0.10% | -6.4% |
| Q3 2019 | $1,351,000 | +6.8% | 15,440 | 0.0% | 0.11% | -1.8% |
| Q2 2019 | $1,265,000 | +0.1% | 15,440 | -0.7% | 0.11% | -0.9% |
| Q1 2019 | $1,264,000 | +22.6% | 15,555 | -0.7% | 0.11% | +5.7% |
| Q4 2018 | $1,031,000 | -14.7% | 15,668 | 0.0% | 0.11% | -0.9% |
| Q3 2018 | $1,208,000 | +4.4% | 15,668 | 0.0% | 0.11% | -2.7% |
| Q2 2018 | $1,157,000 | +11.4% | 15,668 | -2.0% | 0.11% | +11.1% |
| Q1 2018 | $1,039,000 | -0.6% | 15,984 | -1.1% | 0.10% | -6.6% |
| Q4 2017 | $1,045,000 | +2.6% | 16,168 | -0.5% | 0.11% | +3.9% |
| Q3 2017 | $1,019,000 | +2.0% | 16,243 | -1.6% | 0.10% | -2.9% |
| Q2 2017 | $999,000 | +16.4% | 16,506 | -0.1% | 0.10% | +9.4% |
| Q1 2017 | $858,000 | +56.9% | 16,528 | +34.1% | 0.10% | +60.0% |
| Q4 2016 | $547,000 | -23.9% | 12,324 | -18.4% | 0.06% | -25.0% |
| Q3 2016 | $719,000 | +5.3% | 15,109 | -0.0% | 0.08% | +1.3% |
| Q2 2016 | $683,000 | +9.3% | 15,110 | -0.7% | 0.08% | +6.8% |
| Q1 2016 | $625,000 | +2.0% | 15,210 | -5.5% | 0.07% | -7.5% |
| Q4 2015 | $613,000 | -2.7% | 16,090 | -16.1% | 0.08% | -9.1% |
| Q3 2015 | $630,000 | -96.9% | 19,185 | -93.4% | 0.09% | -96.7% |
| Q2 2015 | $20,397,000 | +5.4% | 291,674 | +3.3% | 2.65% | +4.4% |
| Q1 2015 | $19,347,000 | -1.1% | 282,439 | +5.8% | 2.54% | +0.4% |
| Q4 2014 | $19,562,000 | +4.1% | 266,911 | +2.0% | 2.53% | +0.4% |
| Q3 2014 | $18,789,000 | -0.3% | 261,789 | +0.5% | 2.52% | -6.0% |
| Q2 2014 | $18,838,000 | -0.6% | 260,564 | +1.1% | 2.68% | +0.1% |
| Q1 2014 | $18,960,000 | +10.4% | 257,674 | +4.4% | 2.68% | +9.6% |
| Q4 2013 | $17,169,000 | +19.6% | 246,868 | +12.9% | 2.45% | +9.6% |
| Q3 2013 | $14,358,000 | -2.6% | 218,572 | +2.7% | 2.23% | -5.3% |
| Q2 2013 | $14,741,000 | – | 212,801 | – | 2.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |